US Patent No: 6,221,587

Number of patents in Portfolio can not be more than 2000

Identification of molecular interaction sites in RNA for novel drug discovery

1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

Methods of identifying molecular interaction sites in eukaryotic and prokaryotic nucleic acids, especially RNA, are described. Secondary structural elements are identified from highly conserved sequences. Methods of preparing databases relating to such molecular interaction sites are also provided herein as are databases themselves. Therapeutic, agricultural, industrial, and other applicability results from interaction of such molecular interaction sites with "small" and other molecules.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
ISIS PHARMACEUTICALS, INC.CARLSBAD, CA966

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ecker, David J Encinitas, CA 204 3183
Griffey, Richard Vista, CA 47 807
McNeil, John La Jolla, CA 95 2134
Sampath, Ranga San Diego, CA 5 63

Cited Art

Patent Info (Count) # Cites Year
 
CURAGEN CORPORATION (1)
5,977,311 53BP2 complexes 3 1997
 
Other [Check patent profile for assignment information] (1)
5,885,834 Antisense oligodeoxynucleotide against phosphodiesterase 13 1997

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
IBIS BIOSCIENCES, INC. (37)
7,217,510 Methods for providing bacterial bioagent characterizing information 41 2001
7,108,974 Method for rapid detection and identification of bioagents 41 2002
7,781,162 Methods for rapid identification of pathogens in humans and animals 28 2003
7,666,588 Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy 28 2003
7,255,992 Methods for rapid detection and identification of bioagents for environmental and product testing 42 2003
7,226,739 Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations 41 2003
7,718,354 Methods for rapid identification of pathogens in humans and animals 28 2003
8,073,627 System for indentification of pathogens 8 2004
8,057,993 Methods for identification of coronaviruses 9 2004
7,964,343 Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture 1 2004
7,811,753 Methods for repairing degraded DNA 0 2004
8,158,354 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture 5 2004
7,666,592 Methods for concurrent identification and quantification of an unknown bioagent 0 2005
8,119,336 Compositions for use in identification of alphaviruses 0 2005
7,714,275 Mass spectrometry with selective ion filtration by digital thresholding 1 2005
8,163,895 Compositions for use in identification of orthopoxviruses 0 2005
8,017,322 Method for rapid detection and identification of bioagents 9 2005
8,017,358 Method for rapid detection and identification of bioagents 9 2006
7,741,036 Method for rapid detection and identification of bioagents 32 2006
8,182,992 Compositions for use in identification of adventitious viruses 0 2006
8,026,084 Methods for rapid identification and quantitation of nucleic acid variants 9 2006
8,298,760 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby 0 2007
7,956,175 Compositions for use in identification of bacteria 9 2007
8,013,142 Compositions for use in identification of bacteria 3 2007
8,097,416 Methods for identification of sepsis-causing bacteria 2 2007
8,265,878 Method for rapid detection and identification of bioagents 0 2007
8,071,309 Methods for rapid identification of pathogens in humans and animals 8 2007
8,017,743 Method for rapid detection and identification of bioagents 9 2007
8,380,442 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby 0 2007
8,407,010 Methods for rapid forensic analysis of mitochondrial DNA 0 2008
8,268,565 Methods for identifying bioagents 0 2008
8,148,163 Sample processing units, systems, and related methods 0 2009
8,084,207 Compositions for use in identification of papillomavirus 0 2009
8,187,814 Methods for concurrent identification and quantification of an unknown bioagent 0 2010
8,173,957 Mass spectrometry with selective ion filtration by digital thresholding 0 2010
8,158,936 Ionization probe assemblies 0 2010
8,252,599 Sample processing units, systems, and related methods 0 2011
 
PTC THERAPEUTICS, INC. (6)
8,460,864 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same 0 2004
7,829,503 Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents 0 2004
8,283,115 Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation 0 2008
8,283,116 Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation 0 2008
8,278,085 RNA processing protein complexes and uses thereof 0 2008
7,939,468 Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents 0 2010
 
DRIVE SENTRY, INC. (1)
8,214,154 Systems for rapid identification of pathogens in humans and animals 0 2007
 
ISIS PHARMACEUTICALS, INC. (1)
6,451,524 Identification of disease predictive nucleic acids 1 1998
 
LUMINEX CORPORATION (1)
6,941,317 Graphical user interface for display and analysis of biological sequence data 9 1999
 
OPKO CURNA, LLC (1)
8,153,606 Treatment of apolipoprotein-A1 related diseases by inhibition of natural antisense transcript to apolipoprotein-A1 0 2009
 
PTC THERAPEUTICS (1)
8,426,194 Methods and agents for screening for compounds capable of modulating VEGF expression 0 2004
 
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (1)
8,046,171 Methods and apparatus for genetic evaluation 9 2003
 
The Scripps Research Institute (1)
8,288,354 Natural antisense and non-coding RNA transcripts as drug targets 0 2006